Human induced pluripotent stem cell-based models for studying neural repair.
Manasi Agrawal1, Meghal Desai1, Shruti Ghumra1
1Department of Biological Sciences, LSCI, Rutgers University - Newark, 225 University Avenue, Newark, NJ 07102, USA.
Progress in Neurobiology
|March 19, 2026
Summary
Human induced pluripotent stem cells (iPSCs) create advanced models for studying nervous system repair. These models reveal key factors in neural regeneration and aid in developing patient-specific therapies.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Stem Cell Biology
Background:
- Nervous system injuries cause permanent functional loss due to limited regeneration.
- Existing models fail to fully replicate human neural complexity and repair mechanisms.
Purpose of the Study:
- To review advances in human induced pluripotent stem cell (iPSC)-derived models for studying neural repair.
- To highlight how these models overcome limitations of traditional animal systems.
Main Methods:
- Utilizing 2D cultures, 3D organoids/assembloids, and microengineered axon injury platforms.
- Employing iPSC-derived neurons, glial cells, and neuromuscular junction models.
- Incorporating in vivo transplantation studies.
Main Results:
- Identified intracellular regulators of neurite growth and effects of mutations on axonal integrity.
- Enabled high-throughput screening for neuroprotective and pro-regenerative compounds.
- Elucidated axon-glia interactions, remyelination, and circuit repair.
Conclusions:
- Human iPSC-based models provide crucial insights into neural regeneration mechanisms.
- These platforms hold significant promise for developing patient-specific therapies for nervous system injuries.
Keywords:
Axon growthGlial cellsIPSCsNeural repairNeuromuscular junctionsOrganoids and assembloidsRegenerationMore Related Videos
Related Concept Videos
EPS and iPS Cells in Disease Research
3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
Induced Pluripotent Stem Cells
28.5K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.5K
Induced Pluripotent Stem Cells
6.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
6.1K
iPS Cell Differentiation
3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K


